Gregory Kucera's research topics

Gregory Kucera

Concepts (185)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Gregory Kucera's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Gregory Kucera has written about over time.

Cyclooxygenase 2 Inhibitors, 1 publications between 2006 and 2006, average publication date September 2006. Nitrobenzenes, 1 publications between 2006 and 2006, average publication date September 2006. Hyperthermia, Induced, 2 publications between 2006 and 2007, average publication date January 2007. Ovarian Neoplasms, 2 publications between 2006 and 2007, average publication date January 2007. Thiourea, 5 publications between 2002 and 2015, average publication date September 2008. Deoxycytidine, 3 publications between 2003 and 2017, average publication date October 2008. Intercalating Agents, 5 publications between 2002 and 2014, average publication date February 2009. Antineoplastic Agents, 22 publications between 2002 and 2017, average publication date March 2009. Drug Screening Assays, Antitumor, 12 publications between 2002 and 2017, average publication date June 2009. DNA, 7 publications between 2002 and 2014, average publication date July 2009. Organoplatinum Compounds, 5 publications between 2006 and 2014, average publication date August 2009. Acridines, 13 publications between 2002 and 2014, average publication date October 2009. Prodrugs, 2 publications between 2005 and 2014, average publication date December 2009. Drug Design, 8 publications between 2002 and 2014, average publication date April 2010. Drug Resistance, Neoplasm, 3 publications between 2005 and 2017, average publication date May 2010. Lipids, 2 publications between 2005 and 2016, average publication date July 2010. Nucleosides, 2 publications between 2005 and 2016, average publication date July 2010. Platinum, 11 publications between 2008 and 2014, average publication date September 2011. Cell Line, Tumor, 18 publications between 2004 and 2020, average publication date December 2011. Neoplasms, 4 publications between 2005 and 2019, average publication date April 2013.

Cyclooxygenase 2 Inhibitors
Nitrobenzenes
Hyperthermia, Induced
Ovarian Neoplasms
Thiourea
Deoxycytidine
Intercalating Agents
Antineoplastic Agents
Drug Screening Assays, Antitumor
DNA
Organoplatinum Compounds
Acridines
Prodrugs
Drug Design
Drug Resistance, Neoplasm
Lipids
Nucleosides
Platinum
Cell Line, Tumor
Neoplasms

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Cyclooxygenase 2 Inhibitors	1	2006	2006	September 2006
Nitrobenzenes	1	2006	2006	September 2006
Hyperthermia, Induced	2	2006	2007	January 2007
Ovarian Neoplasms	2	2006	2007	January 2007
Thiourea	5	2002	2015	September 2008
Deoxycytidine	3	2003	2017	October 2008
Intercalating Agents	5	2002	2014	February 2009
Antineoplastic Agents	22	2002	2017	March 2009
Drug Screening Assays, Antitumor	12	2002	2017	June 2009
DNA	7	2002	2014	July 2009
Organoplatinum Compounds	5	2006	2014	August 2009
Acridines	13	2002	2014	October 2009
Prodrugs	2	2005	2014	December 2009
Drug Design	8	2002	2014	April 2010
Drug Resistance, Neoplasm	3	2005	2017	May 2010
Lipids	2	2005	2016	July 2010
Nucleosides	2	2005	2016	July 2010
Platinum	11	2008	2014	September 2011
Cell Line, Tumor	18	2004	2020	December 2011
Neoplasms	4	2005	2019	April 2013

Kucera's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (185)

Explore

Co-Authors (18)

Explore

Similar People (49)

Explore

Same Department

Explore

Physical Neighbors